{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T21:34:08Z","timestamp":1780349648187,"version":"3.54.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.wneu.2022.12.003","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T20:50:15Z","timestamp":1670273415000},"page":"e858-e867","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Endoscopic Transnasal Approach for Microprolactinomas with Experience of 105 Cases in a Single Center: Paradigmal Shift for Conventional Medical Therapy"],"prefix":"10.1016","volume":"170","author":[{"given":"Ayse","family":"Uzuner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eren","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4405-0566","authenticated-orcid":false,"given":"Melih","family":"Caklili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alev","family":"Selek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3400-9025","authenticated-orcid":false,"given":"Fatih","family":"Aydemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burak","family":"Cabuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihsan","family":"Anik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2747-8907","authenticated-orcid":false,"given":"Savas","family":"Ceylan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2022.12.003_bib1","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/neuros\/nyy385","article-title":"Endoscopic transsphenoidalsurgery of microprolactinomas: aReappraisal of cure rate based on radiological criteria","volume":"85","author":"Micko","year":"2019","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2022.12.003_bib2","first-page":"377","article-title":"Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)","volume":"72","author":"Fernandez","year":"2010","journal-title":"ClinEndocrinol"},{"key":"10.1016\/j.wneu.2022.12.003_bib3","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1530\/EJE-16-0087","article-title":"Therapyofendocrinedisease: surgery in microprolactinomas: effectiveness and risks based on contemporary literature","volume":"175","author":"Tampourlou","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.wneu.2022.12.003_bib4","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/jama.2016.19699","article-title":"Diagnosis and treatment of pituitary adenomas: areview","volume":"317","author":"Molitch","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.wneu.2022.12.003_bib5","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/er.2005-9998","article-title":"Advances in the treatment of prolactinomas","volume":"27","author":"Gillam","year":"2006","journal-title":"Endocr Rev"},{"key":"10.1016\/j.wneu.2022.12.003_bib6","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1056\/NEJMcp025334","article-title":"Clinical practice Prolactinoma","volume":"349","author":"Schlechte","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2022.12.003_bib7","doi-asserted-by":"crossref","first-page":"101290","DOI":"10.1016\/j.beem.2019.101290","article-title":"The epidemiology, diagnosis and treatment of Prolactinomas: the old and the new","volume":"33","author":"Chanson","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2022.12.003_bib8","first-page":"273","article-title":"Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J\u00a0ClinEndocrinolMetab"},{"key":"10.1016\/j.wneu.2022.12.003_bib9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000497746","article-title":"Epidemiology and management Challenges in prolactinomas","volume":"109","author":"Vroonen","year":"2019","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.wneu.2022.12.003_bib10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrendo.2011.37","article-title":"Medical treatment of prolactinomas","volume":"7","author":"Colao","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.wneu.2022.12.003_bib11","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1210\/jcem.84.7.5810","article-title":"Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients","volume":"84","author":"Verhelst","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2022.12.003_bib12","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1210\/clinem\/dgz144","article-title":"Surgery as a viable alternative first-line treatment for prolactinomapatients. Asystematic review and meta-analysis","volume":"105","author":"ZamanipoorNajafabadi","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2022.12.003_bib13","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s11102-014-0617-2","article-title":"Current drug withdrawal strategy in prolactinoma patients treated with cabergoline: a systematic review and meta-analysis","volume":"18","author":"Hu","year":"2015","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2022.12.003_bib14","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3389\/fendo.2018.00636","article-title":"The chance of permanent cure for Micro- and Macroprolactinomas, medication or surgery?Asystematic review and meta-analysis","volume":"9","author":"Ma","year":"2018","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.wneu.2022.12.003_bib15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11102-019-00989-1","article-title":"Dopamine agonists in prolactinomas: when to withdraw?","volume":"23","author":"Souteiro","year":"2020","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2022.12.003_bib16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s11102-013-0525-x","article-title":"Second attempt to withdraw cabergoline in prolactinomas: a pilot study","volume":"17","author":"Kwancharoen","year":"2014","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2022.12.003_bib17","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s12020-014-0281-3","article-title":"Surgical treatment of microprolactinomas: pros","volume":"47","author":"Salvatori","year":"2014","journal-title":"Endocrine"},{"key":"10.1016\/j.wneu.2022.12.003_bib18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11102-008-0091-9","article-title":"Quality of life in women with microprolactinoma treated with dopamine agonists","volume":"11","author":"Cesar de Oliveira Naliato","year":"2008","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2022.12.003_bib19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1056\/NEJMoa054830","article-title":"Valvular heart disease and the use of dopamine agonists for Parkinson's disease","volume":"356","author":"Zanettini","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2022.12.003_bib20","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s11102-010-0283-y","article-title":"Pituitary surgery for small prolactinomas as an alternative to treatment with dopamine agonists","volume":"14","author":"Babey","year":"2011","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2022.12.003_bib21","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1530\/EJE-21-0293","article-title":"Pituitary surgery as alternative to dopamine agonists treatment for microprolactinomas: a cohort study","volume":"185","author":"Baussart","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.wneu.2022.12.003_bib22","doi-asserted-by":"crossref","first-page":"9930059","DOI":"10.1155\/2021\/9930059","article-title":"Surgery and medical treatment in microprolactinoma: asystematic review and meta-analysis","volume":"2021","author":"Lu","year":"2021","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.wneu.2022.12.003_bib23","doi-asserted-by":"crossref","first-page":"e626","DOI":"10.1016\/j.wneu.2022.10.043","article-title":"Endoscopic endonasal transsphenoidal surgery for patients with prolactinomas: indications and outcomes","volume":"168","author":"Force","year":"2022","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2022.12.003_bib24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2265.2011.04326.x","article-title":"Changes in heart valve structure and function in patients treated with dopamine agonists for prolactinomas, a 2-year follow-up study","volume":"77","author":"Delgado","year":"2012","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.wneu.2022.12.003_bib25","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1210\/jc.2013-2254","article-title":"A\u00a0cross-sectional study of the prevalence of cardiac valvular abnormalities in hyperprolactinemic patients treated with ergot-derived dopamine agonists","volume":"99","author":"Drake","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2022.12.003_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa062222","article-title":"Dopamine agonists and the risk of cardiac-valve regurgitation","volume":"356","author":"Schade","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2022.12.003_bib27","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11102-010-0261-4","article-title":"Effect of dopaminergic drug treatment on surgical findings in prolactinomas","volume":"14","author":"Menucci","year":"2011","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2022.12.003_bib28","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jocn.2015.03.059","article-title":"Update on prolactinomas. Part 2: treatment and management strategies","volume":"22","author":"Wong","year":"2015","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.wneu.2022.12.003_bib29","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1530\/EJE-11-1000","article-title":"Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients","volume":"166","author":"Primeau","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.wneu.2022.12.003_bib30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4158\/EP13165.RA","article-title":"Effect of the preoperative use of dopamine agonists in the postoperative course of prolactinomas: a systematic review","volume":"20","author":"Carija","year":"2014","journal-title":"Endocr Pract"},{"key":"10.1016\/j.wneu.2022.12.003_bib31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/EJE-07-0248","article-title":"Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients","volume":"158","author":"Kreutzer","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.wneu.2022.12.003_bib32","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0090-3019(95)00430-0","article-title":"Transsphenoidaladenomectomy for microprolactinomas: 10 to 20 years of follow-up","volume":"45","author":"Massoud","year":"1996","journal-title":"Surg Neurol"},{"key":"10.1016\/j.wneu.2022.12.003_bib33","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1210\/jc.2003-030461","article-title":"Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: mortality, morbidity, and the effects of hospital and surgeon volume","volume":"88","author":"Barker","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2022.12.003_bib34","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3325\/cmj.2012.53.224","article-title":"Endocrinological outcomes of pure endoscopic transsphenoidal surgery: a Croatian Referral Pituitary Center experience","volume":"53","author":"Mari\u0107","year":"2012","journal-title":"Croat Med J"},{"key":"10.1016\/j.wneu.2022.12.003_bib35","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1227\/NEU.0b013e31827b966a","article-title":"Endoscopic transsphenoidal surgery for cushing disease: techniques, outcomes, and predictors of remission","volume":"72","author":"Starke","year":"2013","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2022.12.003_bib36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.wneu.2015.10.090","article-title":"Cost-effectiveness analysis of microscopic and endoscopic transsphenoidalsurgery versus medical therapy in the management of microprolactinoma in the United States","volume":"87","author":"Jethwa","year":"2016","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2022.12.003_bib37","first-page":"125","article-title":"Cost-effectiveness analysis of surgical versus medical treatment of prolactinomas","volume":"78","author":"Zygourakis","year":"2017","journal-title":"J\u00a0NeurolSurg B Skull Base"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875022016977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875022016977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:14:07Z","timestamp":1761815647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875022016977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":37,"alternative-id":["S1878875022016977"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2022.12.003","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endoscopic Transnasal Approach for Microprolactinomas with Experience of 105 Cases in a Single Center: Paradigmal Shift for Conventional Medical Therapy","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2022.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}